Home Cart Sign in  
Chemical Structure| 65899-73-2 Chemical Structure| 65899-73-2

Structure of Tioconazole
CAS No.: 65899-73-2

Chemical Structure| 65899-73-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Tioconazole is an imidazole antifungal used to treat infections caused by a fungus or yeast, working by disrupting cell wall synthesis through inhibiting the biosynthesis of ergosterol or other sterols.

Synonyms: UK-20349; (±)-Tioconazole; Vagistat.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Tioconazole

CAS No. :65899-73-2
Formula : C16H13Cl3N2OS
M.W : 387.71
SMILES Code : ClC1=CC=C(C(OCC2=C(Cl)SC=C2)CN3C=CN=C3)C(Cl)=C1
Synonyms :
UK-20349; (±)-Tioconazole; Vagistat.
MDL No. :MFCD00057276
InChI Key :QXHHHPZILQDDPS-UHFFFAOYSA-N
Pubchem ID :5482

Safety of Tioconazole

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MDA-MB-231 cells 40 μM 6 h To evaluate the effect of Tioconazole on autophagic flux, results showed that Tioconazole diminished autophagic flux. PMC5771097
H4 cells 40 μM 8 h To evaluate the effect of Tioconazole on GFP-LC3 puncta, results showed that Tioconazole increased the number of GFP-LC3 puncta. PMC5771097
HCT116 cells 40 μM 6 h To evaluate the effect of Tioconazole on autophagic flux, results showed that Tioconazole increased the accumulation of autophagosomes and reduced the fusion of autophagosomes with lysosomes. PMC5771097
Aspergillus fumigatus 5.8 µg/mL (MIC), 34.2 µg/mL (MFC) 48 h To evaluate the minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) of Tioconazole against Candida albicans and Aspergillus fumigatus. PMC10530999
Candida albicans 2.8 µg/mL (MIC), 24.4 µg/mL (MFC) 48 h To evaluate the minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) of Tioconazole against Candida albicans and Aspergillus fumigatus. PMC10530999

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice HCT116 tumor xenograft model Intraperitoneal injection 60 mg/kg Every other day for 21 days To evaluate the effect of Tioconazole on tumor growth, results showed that Tioconazole reduced tumor volumes and enhanced the efficacy of chemotherapeutic drugs. PMC5771097
Albino rats Candida albicans infected skin model Topical application 0.01 Once daily for 12 days To evaluate the efficacy of TCZ-loaded TEG04 gel in treating Candida albicans infection, results showed comparable therapeutic effect to the market brand Canesten?. PMC10530999

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.58mL

0.52mL

0.26mL

12.90mL

2.58mL

1.29mL

25.79mL

5.16mL

2.58mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories